A retrospective analysis of post second-line chemotherapy treatment outcomes for patients with advanced or metastatic cholangiocarcinoma and FGFR2 fusions.

被引：0
作者：
Javle, Milind M.
Sadeghi, Saeed
El-Khoueiry, Anthony B.
Goyal, Lipika
Philip, Philip Agop
Kelley, Robin Kate
Borbath, Ivan
Macarulla, Teresa
Yong, Wei-Peng
Tanasanvimon, Suebpong
Pande, Amit
Li, Gary
Howland, Michael
Berman, Craig
Abou-Alfa, Ghassan K.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Calif Los Angeles, Santa Monica, CA USA
[3] USC Kenneth Norris Comprehens Canc Ctr, Los Angeles, CA USA
[4] Massachusetts Gen Hosp, Boston, MA 02114 USA
[5] Karmanos Canc Inst, Detroit, MI USA
[6] Univ Calif San Francisco, San Francisco, CA 94143 USA
[7] Clin Univ St Luc, Brussels, Belgium
[8] Hosp Valle De Hebron, Barcelona, Spain
[9] Natl Univ Canc Inst, Singapore, Singapore
[10] Chulalongkorn Univ, Bangkok, Thailand
[11] QED Therapeut Inc, San Francisco, CA USA
[12] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4591
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Use, response and outcomes of second-line chemotherapy in patients with advanced biliary tract cancers
    Mathers, Brittney
    Abadi, Shirin
    Davies, Janine M.
    McIntyre, Connor
    Ho, Cheryl
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, : 1381 - 1386
  • [42] Impact of muscle mass loss on outcomes in advanced or metastatic gastric cancer patients receiving a second-line treatment
    Zurlo, V.
    Rosa, F.
    Rinninella, E.
    Pontolillo, L.
    Beccia, V.
    Maratta, M.
    Tortora, G.
    Alfieri, S.
    Pozzo, C.
    Strippoli, A.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2024, 28 (04) : 1575 - 1584
  • [43] A phase 2 study of HMPL-453, a selective FGFR tyrosine kinase inhibitor (TKI), in patients with previously treated advanced cholangiocarcinoma containing FGFR2 fusions
    Xu, Jianming
    Xiong, Jianping
    Gu, Shanzhi
    Niu, Zuoxing
    Yin, Fei
    Sun, Beicheng
    Zhang, Lan
    Zhou, Fuxiang
    Hao, Chunyi
    Pan, Yueyin
    Qiu, Wensheng
    Gao, Yi
    Ren, Yongxin
    Fan, Songhua
    Shi, Michael
    Su, Weiguo
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [44] Infigratinib versus gemcitabine plus cisplatin as first-line therapy in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: phase 3 PROOF trial
    Abou-Alfa, G.
    Borbath, I.
    Cohn, A.
    Goyal, L.
    Lamarca, A.
    Macarulla, T.
    Oh, D.
    Roychowdhury, S.
    Sadeghi, S.
    Shroff, R.
    Howland, M.
    Li, A.
    Cho, T.
    Pande, A.
    Javle, M.
    ANNALS OF ONCOLOGY, 2020, 31 : S136 - S137
  • [45] Re: Second-Line Chemotherapy in Older Patients with Metastatic Urothelial Carcinoma: Pooled Analysis of 10 Second-Line Studies Editorial Comment
    Griebling, Tomas L.
    JOURNAL OF UROLOGY, 2018, 199 (03) : 591 - 592
  • [46] Multivariate prognostic factor analysis to predict survival following second-line chemotherapy in patients with advanced and metastatic gastric cancer
    Catalano, Vincenzo
    Graziano, Francesco
    Santini, Daniele
    D'Emidio, Silvia
    Baldelli, Anna Maria
    Rossi, David
    Vincenzi, Bruno
    Giordani, Paolo
    Testa, Enrica
    Tonini, Giuseppe
    Catalano, Giuseppina
    ANNALS OF ONCOLOGY, 2007, 18 : 8 - 8
  • [47] EFFICACY ANALYSIS OF APATINIB COMBINED WITH CHEMOTHERAPY IN THE TREATMENT OF ADVANCED SECOND-LINE GASTRIC CANCER
    Fan, Cuizhen
    Guo, Hongqiang
    Chu, Yuping
    An, Guangyu
    ACTA MEDICA MEDITERRANEA, 2022, 38 (01): : 1 - 5
  • [48] Treatment Sequencing and Independent Outcomes of First- and Second-Line Chemotherapy in a Retrospective Series of Patients with Biliary Tract Cancer
    Frega, Giorgio
    Palloni, Andrea
    Deiana, Chiara
    Rizzo, Alessandro
    Ricci, Angela Dalia
    Brandi, Giovanni
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (23)
  • [49] Second-line treatment patterns and outcomes of metastatic bladder cancer patients in clinical practice
    Flannery, K.
    Black-Shinn, J.
    Boyd, M.
    Robert, N.
    Kamat, A.
    ANNALS OF ONCOLOGY, 2017, 28
  • [50] Real-world outcomes among patients with advanced or metastatic biliary tract cancers initiating second-line treatment
    Cosgrove, David P.
    Reese, Emily S.
    Fulcher, Nicole M.
    Bobiak, Sarah S.
    Lamy, Francois-Xavier
    Allignol, Arthur
    Boyd, Marley
    Mahmoudpour, Seyed H.
    CANCER MEDICINE, 2023, 12 (04): : 4195 - 4205
12345